Clinical Trials Directory

Trials / Completed

CompletedNCT00457262

Effects of Soy Protein on Serum paraoxonase1 Activity and Lipoproteins in Postmenopausal Women

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
42 (planned)
Sponsor
Iran University of Medical Sciences · Academic / Other
Sex
Female
Age
51 Years – 57 Years
Healthy volunteers
Accepted

Summary

paraoxonase 1 is involved to prevent LDL and HDL oxidation,so increase of it's activity leads to lower risk of coronary heart disease.In postmenopausal women ,we have decrease of paraoxonase1 activity and soy proteins may increase paraoxonase1 activity

Detailed description

In a double blind clinical randomised clinical trial with parallel design this study was done.52 postmenopausal women were randomly assigned to 50 g/d soy protein or placebo for 10 weeks.serum lipoproteins and pon1 activity were measured at baseline and 10th week.There were significant increase in PON! activity and significant decrease in LDL-C,LDL-C/HDL-C,TC/HDL-C and TG/HDL-C in soy group compare to placebo group.

Conditions

Interventions

TypeNameDescription
PROCEDUREsoy consumption

Timeline

Start date
2006-01-01
Completion
2006-08-01
First posted
2007-04-06
Last updated
2007-04-06

Source: ClinicalTrials.gov record NCT00457262. Inclusion in this directory is not an endorsement.

Effects of Soy Protein on Serum paraoxonase1 Activity and Lipoproteins in Postmenopausal Women (NCT00457262) · Clinical Trials Directory